FDA product code DQO: Catheter, Intravascular, Diagnostic

DQO is the FDA product code for catheter, intravascular, diagnostic. It is a Class II device, regulated under 21 CFR 870.1200 and reviewed by the Cardiovascular panel. FDA has cleared 501 510(k) submissions under DQO, 17 in the last five years, from 204 different applicants. The average 510(k) review took 122 days (median 88); 140 days on average over the last three years. FDA has posted 285 recalls for DQO devices, 83 initiated in the last five years.

Classification

FieldValue
Device nameCatheter, Intravascular, Diagnostic
Device classClass II
Regulation21 CFR 870.1200
Review panelCV — Cardiovascular
Medical specialtyCardiovascular
Premarket route510(k)
Third-party 510(k) review eligibleYes

510(k) clearances per year for DQO

YearClearancesAvg. review days
201710169
201810188
20196138
2020385
20211253
20224177
2023482
20244155
20252127
20263138

Compare with all 510(k) review times · Search every DQO clearance

Top DQO applicants

ApplicantClearancesLatest
Cordis Corp.282002-03-20
Boston Scientific Corp192012-09-14
Scimed Life Systems, Inc.161998-08-18
C.R. Bard, Inc.161998-05-15
AngioDynamics, Inc.112018-07-18

199 more applicants have DQO clearances. See the full list in Caduvo.

Most recent DQO clearances

510(k)ApplicantDeviceDecision dateReview days
K261455Spectrum VascularArterial Pressure Monitoring Set/Tray2026-06-2656
K252702Bioptimal International Pte. , Ltd.Bioptimal Pulmonary Artery Monitoring Catheter (TD2502NF, TD2502NGF, TD2502NDF, TD2502NCF, TD2502NCGF, TD2502NDGF, TD2502NDCF, TD2502NDCGF, TD2502NXCF, TD2502NDXF, TD2502NXCGF, TD2502NDXGF, TD2502NDXCF, TD2502NDXCGF, TD2502-110NF, TD2502-110NGF, TD2502-110NDF, TD2502-110NCF, TD2502-110NDGF, TD2502-110NDCF, TD2502-110NCGF, TD2502-110NDCGF, TD2502-110NXF, TD2502-110NXGF, TD2502-110NDXF, TD2502-110NXCF, TD2502-110NDXGF, TD2502-110NDXCF ,TD2502-110NXCGF, TD2502-110NDXCGF, TD2602NF, TD2602N2026-05-28274
K254278Spectrum VascularArterial Pressure Monitoring Set/Tray2026-03-2585
K250751Terumo CorporationDualView Catheter2025-07-17127
K242966Gentuity, LLCGentuity® HF-OCT Imaging System with Vis-Rx Prime® Micro-Imaging Catheter2025-01-31127

Recalls for DQO devices

285 product recalls in 79 recall events; 83 initiated in the last five years and 84 still open. Most recent: 2026-08-24.

YearRecalls
201714
20184
201971
20206
20215
20223
20232
202451
20251
202626

Frequently asked questions

What is FDA product code DQO?

DQO is the FDA product code for catheter, intravascular, diagnostic. It is a Class II device, regulated under 21 CFR 870.1200 and reviewed by the Cardiovascular panel.

What device class is DQO?

Class II, regulation 21 CFR 870.1200. Typical premarket route: 510(k).

How long does a 510(k) take for product code DQO?

Across 501 cleared submissions the average was 122 days from receipt to decision (median 88).

Which companies have the most DQO clearances?

Cordis Corp. (28); Boston Scientific Corp (19); Scimed Life Systems, Inc. (16); C.R. Bard, Inc. (16); AngioDynamics, Inc. (11).

Have DQO devices been recalled?

Yes: 285 product recalls across 79 recall events; the most recent began 2026-08-24.

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Cardiovascular product codes · FDA product code lookup · 510(k) database search · 510(k) review times